Analysis Metabolite Name Measured Value Units Sample TREATMENT
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.645Peak areaPlasma Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.7379Peak areaPlasma Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.7733Peak areaPlasma Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.7996Peak areaPlasma Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.8122Peak areaPlasma Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.827Peak areaPlasma Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.8604Peak areaPlasma Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.8723Peak areaPlasma Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.9008Peak areaPlasma Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.9224Peak areaPlasma Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.946Peak areaPlasma Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.994Peak areaPlasma Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.006Peak areaPlasma Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.0212Peak areaPlasma Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.0348Peak areaPlasma Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.0476Peak areaPlasma Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.0544Peak areaPlasma Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.0853Peak areaPlasma Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.149Peak areaPlasma Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.1885Peak areaPlasma Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.2175Peak areaPlasma Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.2984Peak areaPlasma Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.3308Peak areaPlasma Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.4206Peak areaPlasma Angiotensin II

Return to search page
  logo